344 related articles for article (PubMed ID: 17660615)
1. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
2. Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Meyer T; Ruppert V; Karatolios K; Maisch B
J Electrocardiol; 2007; 40(6):504-9. PubMed ID: 17289071
[TBL] [Abstract][Full Text] [Related]
3. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Lankisch TO; Jaeckel E; Strassburg CP
Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge.
Jääskeläinen J; Perheentupa J
Pediatr Endocrinol Rev; 2009 Dec; 7(2):15-28. PubMed ID: 20118890
[TBL] [Abstract][Full Text] [Related]
5. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.
Mayer A; Ploix C; Orgiazzi J; Desbos A; Moreira A; Vidal H; Monier JC; Bienvenu J; Fabien N
J Clin Endocrinol Metab; 2004 Sep; 89(9):4484-8. PubMed ID: 15356052
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
[TBL] [Abstract][Full Text] [Related]
7. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.
Gylling M; Kääriäinen E; Väisänen R; Kerosuo L; Solin ML; Halme L; Saari S; Halonen M; Kämpe O; Perheentupa J; Miettinen A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4602-8. PubMed ID: 14557429
[TBL] [Abstract][Full Text] [Related]
8. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism.
Charrié A; Chikh K; Peix JL; Berger N; Decaussin M; Veber S; Bienvenu J; Lifante JC; Fabien N
Clin Chim Acta; 2009 Aug; 406(1-2):94-7. PubMed ID: 19520070
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.
Kemp EH; Habibullah M; Kluger N; Ranki A; Sandhu HK; Krohn KJ; Weetman AP
J Clin Endocrinol Metab; 2014 Mar; 99(3):1064-71. PubMed ID: 24423312
[TBL] [Abstract][Full Text] [Related]
11. Absence of pathogenic calcium sensing receptor mutations in sporadic idiopathic hypoparathyroidism.
Sarin R; Tomar N; Ray D; Gupta N; Sharma YD; Goswami R
Clin Endocrinol (Oxf); 2006 Sep; 65(3):359-63. PubMed ID: 16918956
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.
Chamberlin M; Kemp EH; Weetman AP; Khadka B; Brown EM
Clin Endocrinol (Oxf); 2019 Jan; 90(1):214-221. PubMed ID: 30358904
[TBL] [Abstract][Full Text] [Related]
13. Hypoparathyroidism and autoimmune polyendocrine syndromes.
Schott M; Scherbaum WA
N Engl J Med; 2004 Sep; 351(10):1032-3; author reply 1032-3. PubMed ID: 15342816
[No Abstract] [Full Text] [Related]
14. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
15. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.
Gavalas NG; Kemp EH; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2007 Jun; 92(6):2107-14. PubMed ID: 17374709
[TBL] [Abstract][Full Text] [Related]
16. Lupus-like panniculitis in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Füchtenbusch M; Vogel A; Achenbach P; Gummer M; Ziegler AG; Albert E; Standl E; Manns MP
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):288-93. PubMed ID: 12951636
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria?
Buzi F; Badolato R; Mazza C; Giliani S; Notarangelo LD; Radetti G; Plebani A; Notarangelo LD
J Clin Endocrinol Metab; 2003 Jul; 88(7):3146-8. PubMed ID: 12843157
[TBL] [Abstract][Full Text] [Related]
18. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients.
Pöntynen N; Miettinen A; Arstila TP; Kämpe O; Alimohammadi M; Vaarala O; Peltonen L; Ulmanen I
J Autoimmun; 2006 Sep; 27(2):96-104. PubMed ID: 16820279
[TBL] [Abstract][Full Text] [Related]
19. Translational implications of the parathyroid calcium receptor.
Stewart AF
N Engl J Med; 2004 Jul; 351(4):324-6. PubMed ID: 15269311
[No Abstract] [Full Text] [Related]
20. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Brown EM
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
